scholarly article | Q13442814 |
P50 | author | Alessandra Puddu | Q59194506 |
Giorgio Luciano Viviani | Q59194510 | ||
Fabrizio Montecucco | Q41112895 | ||
P2093 | author name string | Roberta Sanguineti | |
P2860 | cites work | The pathogenesis of NIDDM involves a defective expression of the GIP receptor | Q58449027 |
Incretin effect due to increased secretion and decreased clearance of insulin in normal humans | Q68149026 | ||
Reduced incretin effect in type 2 (non-insulin-dependent) diabetes | Q68865252 | ||
Expression and functional activity of glucagon, glucagon-like peptide I, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells | Q70869265 | ||
Plasma levels of pentosidine in diabetic patients: an advanced glycation end product | Q77197610 | ||
A sensitive and specific ELISA for plasma pentosidine | Q77292141 | ||
Downregulation of GLP-1 and GIP receptor expression by hyperglycemia: possible contribution to impaired incretin effects in diabetes | Q79953668 | ||
Reversal of islet GIP receptor down-regulation and resistance to GIP by reducing hyperglycemia in the Zucker rat | Q81096377 | ||
The role of "metabolic memory" in the natural history of diabetes mellitus | Q84583263 | ||
Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses | Q93538767 | ||
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes | Q28273497 | ||
A novel pathway for regulation of glucose-dependent insulinotropic polypeptide (GIP) receptor expression in beta cells | Q28567736 | ||
Chronic desensitization of the glucose-dependent insulinotropic polypeptide receptor in diabetic rats | Q28570330 | ||
Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction | Q29618388 | ||
Is the diminished incretin effect in type 2 diabetes just an epi-phenomenon of impaired beta-cell function? | Q33803409 | ||
Advanced glycation end-products: a review | Q34196489 | ||
Glucagon-like peptide 1(GLP-1) in biology and pathology | Q34401791 | ||
Gastric inhibitory polypeptide: the neglected incretin revisited | Q34758871 | ||
The role of incretins in glucose homeostasis and diabetes treatment | Q34901533 | ||
Advanced glycation end-products and the progress of diabetic vascular complications. | Q35717287 | ||
Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus | Q35824086 | ||
Clinical endocrinology and metabolism. Glucose-dependent insulinotropic polypeptide/gastric inhibitory polypeptide | Q35943434 | ||
Clinical review 2: The "metabolic memory": is more than just tight glucose control necessary to prevent diabetic complications? | Q37344529 | ||
Glucagon-like peptide-1 secreting cell function as well as production of inflammatory reactive oxygen species is differently regulated by glycated serum and high levels of glucose | Q37598515 | ||
Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory | Q37667703 | ||
The incretin concept today | Q39227026 | ||
Glucagon-like peptide-1 counteracts the detrimental effects of Advanced Glycation End-Products in the pancreatic beta cell line HIT-T 15. | Q39685254 | ||
Advanced glycation end-products affect transcription factors regulating insulin gene expression | Q39720923 | ||
New developments in the incretin concept | Q39832287 | ||
Glycated fetal calf serum affects the viability of an insulin-secreting cell line in vitro. | Q40025987 | ||
Glucose-dependent insulinotropic polypeptide (GIP) stimulation of pancreatic beta-cell survival is dependent upon phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB) signaling, inactivation of the forkhead transcription factor Foxo1, and dow | Q40437409 | ||
Mechanisms of mitogenic and anti-apoptotic signaling by glucose-dependent insulinotropic polypeptide in beta(INS-1)-cells | Q40710884 | ||
Glucose-dependent insulinotropic polypeptide is a growth factor for beta (INS-1) cells by pleiotropic signaling | Q40784305 | ||
Glucose-dependent insulinotropic polypeptide stimulates insulin secretion via increased cyclic AMP and [Ca2+]1 and a wortmannin-sensitive signalling pathway | Q41184207 | ||
The influence of GLP-1 on glucose-stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects | Q42436041 | ||
Defective glucose-dependent insulinotropic polypeptide receptor expression in diabetic fatty Zucker rats. | Q42503767 | ||
Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations | Q42511153 | ||
Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes | Q43778779 | ||
Pentosidine as a biomarker for microvascular complications in type 2 diabetic patients | Q46395512 | ||
P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 326359 | |
P577 | publication date | 2015-06-29 | |
P1433 | published in | Journal of Diabetes Research | Q26841822 |
P1476 | title | Effects of High Glucose Levels and Glycated Serum on GIP Responsiveness in the Pancreatic Beta Cell Line HIT-T15. | |
P478 | volume | 2015 |
Search more.